Effect of weight-adjusted intermediate-dose versus fixed-dose prophylactic anticoagulation with low-molecular-weight heparin on venous thromboembolism among noncritically and critically ill patients with COVID-19: the COVI-DOSE trial, a multicenter, randomised, open-label, phase 4 trialStéphane Zuily, Emmanuel Oger, Guillaume de Ciancio et al.|EClinicalMedicine|2023Cited by 16
Poussées récurrentes de pancréatite précessives d’un purpura rhumatoïdeS. Redl, Y. Imbert, H. Razafindrazaka et al.|La Revue de Médecine Interne|2020Cited by 0